Year archive

IMUGENE LIMITED — 2024 filings

All 70 regulatory filings released by IMUGENE LIMITED (IMU) in 2024, sourced directly from the official regulator.

70 Filings

2024 Period

2024 filings (70)

Filing	Released	Lang
Proposed issue of securities - IMU 6 pages 23.5KB Capital/Financing Update	2024-12-23	English
Issuance of Convertible Notes & Warrants for up to $46m 9 pages 325.8KB Capital/Financing Update	2024-12-22	English
Notice of Extraordinary General Meeting/Proxy Form 22 pages 568.9KB Proxy Solicitation & Information Statement	2024-12-22	English
Azer-cel Accepted for Presentation at ASTCT Tandem Meetings 3 pages 157.5KB Investor Presentation	2024-12-19	English
Imugene Confirms Pending Receipt of c.$11m R&D Tax Refund 2 pages 155.2KB Regulatory Filings	2024-12-18	English
Final Director's Interest Notice 2 pages 4.7KB Director's Dealing	2024-11-19	English
Updated Appendix 3Z 4 pages 171.8KB Director's Dealing	2024-11-19	English
Director Resignation 2 pages 172.9KB Board/Management Information	2024-11-14	English
Imugene AGM Presentation 18 pages 2.4MB AGM Information	2024-11-13	English
Imugene 2024 AGM Results 4 pages 196.5KB Declaration of Voting Results & Voting Rights Announcements	2024-11-13	English
onCARlytics Trial Doses First Patient in IT Combination Arm 3 pages 204.6KB Capital/Financing Update	2024-11-10	English
Imugene Opens First Australian Site for azer-cel Trial 4 pages 231.6KB Regulatory Filings	2024-11-07	English
Complete Response in MAST Study Maintained Over Two Years 3 pages 209.0KB Capital/Financing Update	2024-11-04	English
Quarterly Activities/Appendix 4C Cash Flow Report 10 pages 544.0KB Interim / Quarterly Report	2024-10-30	English
Notice of Annual General Meeting/Proxy Form 47 pages 1.1MB AGM Information	2024-10-13	English
Application for quotation of securities - IMU 8 pages 21.0KB Capital/Financing Update	2024-10-13	English
Notification of cessation of securities - IMU 6 pages 19.3KB Regulatory Filings	2024-10-13	English
Notification regarding unquoted securities - IMU 9 pages 24.4KB Share Issue/Capital Change	2024-10-13	English
Change of Director's Interest Notice - PH 3 pages 284.0KB Director's Dealing	2024-09-29	English
Imugene Receives Orphan Drug Designation for VAXINIA 3 pages 255.0KB Capital/Financing Update	2024-09-17	English
Appendix 2A 21 pages 615.2KB Regulatory Filings	2024-09-10	English
Imugene Corporate Presentation 32 pages 4.1MB Investor Presentation	2024-09-08	English
Imugene Azer-cel Webinar Presentation 14 pages 1.5MB Investor Presentation	2024-09-03	English
Application for quotation of securities - IMU 8 pages 21.1KB Regulatory Filings	2024-09-03	English
Cleansing Notice 2 pages 213.7KB Share Issue/Capital Change	2024-09-03	English
Imugene Webinar - Azer-cel Trial Update 2 pages 227.9KB Investor Presentation	2024-09-02	English
Three Complete Responses in Azer-Cel Phase 1b Trial 6 pages 347.5KB Capital/Financing Update	2024-09-01	English
Appendix 4E and Annual Report 113 pages 6.1MB Regulatory Filings	2024-08-29	English
Corporate Governance Statement 2024 and Appendix 4G 26 pages 728.0KB Governance Information	2024-08-29	English
Imugene ESG Report 2024 20 pages 2.9MB Regulatory Filings	2024-08-29	English
Release of Shares from Voluntary Escrow 2 pages 133.5KB Share Issue/Capital Change	2024-08-01	English
Quarterly Activities/Appendix 4C Cash Flow Report 12 pages 552.6KB Interim / Quarterly Report	2024-07-30	English
Notification regarding unquoted securities - IMU 9 pages 23.3KB Share Issue/Capital Change	2024-07-11	English
Notification of cessation of securities - IMU 6 pages 19.6KB Regulatory Filings	2024-07-11	English
First patient dosed in Phase 1 bile tract cancer trial 4 pages 395.1KB Regulatory Filings	2024-07-09	English
Application for quotation of securities - IMU 9 pages 26.1KB Share Issue/Capital Change	2024-07-07	English
Change of Director's Interest Notice x6 12 pages 69.7KB Director's Dealing	2024-07-07	English
Imugene Corporate Presentation 33 pages 2.5MB Investor Presentation	2024-07-03	English
Imugene onCARlytics Doses First Patient in IV Combination 4 pages 185.7KB Regulatory Filings	2024-06-23	English
Imugene Presentation to Bell Potter Conference 28 pages 2.2MB Investor Presentation	2024-05-29	English
Application for quotation of securities - IMU 8 pages 20.9KB Share Issue/Capital Change	2024-05-05	English
Quarterly Activities/Appendix 4C Cash Flow Report 13 pages 595.0KB Interim / Quarterly Report	2024-04-29	English
Change of Director's Interest Notice - PH 2 pages 6.2KB Director's Dealing	2024-04-22	English
Notification regarding unquoted securities - IMU 9 pages 24.6KB Share Issue/Capital Change	2024-04-18	English
Imugene & Kincell Bio Strategic Partnership Investor Webinar 2 pages 151.9KB Regulatory Filings	2024-04-16	English
Imugene and Kincell Bio Announce Strategic Partnership 4 pages 242.0KB Capital/Financing Update	2024-04-15	English
Bile Tract Cancer Study Opens after MAST High Dose Clearance 4 pages 237.2KB Regulatory Filings	2024-04-14	English
Notification regarding unquoted securities - IMU 8 pages 21.0KB Share Issue/Capital Change	2024-04-14	English
Notification of cessation of securities - IMU 5 pages 17.1KB Regulatory Filings	2024-04-14	English
VAXINIA and HER-Vaxx featured at the AACR Annual Meeting 5 pages 195.8KB Regulatory Filings	2024-04-07	English
Oncolytic Virotherapy CF33 Patent Granted in China 2 pages 177.3KB Regulatory Filings	2024-04-03	English
Imugene to present at 2024 Cholangiocarcinoma Conference 3 pages 175.4KB Regulatory Filings	2024-04-02	English
Application for quotation of securities - IMU 9 pages 24.0KB Share Issue/Capital Change	2024-04-01	English
Cleansing Notice 3 pages 145.0KB Capital/Financing Update	2024-04-01	English
Phase 1 onCARlytics Trial Advances to Combination Arm 3 pages 212.7KB Regulatory Filings	2024-03-10	English
Half Yearly Report and Accounts 32 pages 1.3MB Interim / Quarterly Report	2024-02-28	English
Phase 1 onCARlytics Trial Doses First Intravenous Patient 3 pages 211.6KB Regulatory Filings	2024-02-14	English
Notice of change of interests of substantial holder - PH 4 pages 232.7KB Major Shareholding Notification	2024-02-01	English
Application for quotation of securities - IMU 8 pages 31.0KB Share Issue/Capital Change	2024-01-31	English
Application for quotation of securities - IMU 8 pages 30.4KB Share Issue/Capital Change	2024-01-31	English
Cleansing Notice 3 pages 214.6KB Capital/Financing Update	2024-01-31	English
Change of Director's Interest Notice - PH 2 pages 6.2KB Director's Dealing	2024-01-31	English
Quarterly Activities/Appendix 4C Cash Flow Report 14 pages 588.3KB Interim / Quarterly Report	2024-01-30	English
VAXINIA Phase 1 trial doses patients in higher dose cohorts 4 pages 259.3KB Regulatory Filings	2024-01-18	English
Imugene CF33-hNIS (VAXINIA) & MAST Study Featured at ASCO GI 3 pages 207.9KB Regulatory Filings	2024-01-18	English
Change of Director's Interest Notice x6 12 pages 33.8KB Director's Dealing	2024-01-18	English
Update - Notification regarding unquoted securities - IMU 12 pages 45.9KB Share Issue/Capital Change	2024-01-17	English
Notification regarding unquoted securities - IMU 12 pages 46.2KB Share Issue/Capital Change	2024-01-16	English
Phase 1 CF33-hNIS Study Update - Positive Early Signals 5 pages 200.3KB Capital/Financing Update	2024-01-16	English
Imugene Presentation to JPMorgan Healthcare Conference 35 pages 5.0MB Investor Presentation	2024-01-09	English

Filings by year

2026 52 filings
2025 103 filings
2024 70 filings
2023 105 filings
2022 122 filings
2021 150 filings
2020 90 filings
2019 69 filings
2018 66 filings
2017 58 filings
2016 52 filings
2015 60 filings
2014 57 filings
2013 64 filings
2012 41 filings
2011 13 filings
2010 20 filings
2009 17 filings
2008 34 filings
2007 35 filings
2006 29 filings
2005 31 filings
2004 50 filings
2003 40 filings
2002 12 filings